Reading List

The most recent articles from a list of feeds I subscribe to.

DeepL launches real-time voice-to-voice translation in 40+ languages


The Cologne-based translation company best known for its text tools has unveiled a full voice product suite covering meetings, conversations, group settings, and an API for enterprise integration. A live demo in Seoul showed one-to-two sentence delays, and DeepL’s CPO acknowledged word order differences between languages remain a fundamental challenge. DeepL, the Cologne-based language AI […]



This story continues at The Next Web

AlixLabs closes €15M Series A to commercialise the atomic etching technology


AlixLabs, the Lund-based semiconductor process startup developing Atomic Pitch Splitting (APS™), has completed its €15M Series A with a strategic top-up from Finnish investor Stephen Industries. The company is targeting beta testing with chipmakers in 2026 and manufacturing deployment by 2027. AlixLabs, a deep-tech semiconductor startup based in Lund, Sweden, has closed its €15 million […]



This story continues at The Next Web

Ericsson narrowly misses Q1 profit forecasts as North America unwind


The Swedish telecoms equipment maker narrowly missed profit forecasts, with adjusted EBITA falling 20% year-on-year to SEK 5.6 billion. North America, which drove a 20%+ surge in Q1 2025, declined sharply as prior-year pull-forward investment unwinds. CEO Ekholm blames rising semiconductor input costs, partly driven by AI demand. Ericsson reported a sharp fall in profitability […]



This story continues at The Next Web

OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research


Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific. OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life […]



This story continues at The Next Web

Stockholm’s BioLamina secures €20M EIB loan to scale the protein matrices that make cell therapies possible


The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]



This story continues at The Next Web